Buyers should require the injection molding supplier to submit a written change notice before implementing any change that could affect the approved part, tool, process, inspection method, material, production location, or supply chain. The notice should identify the affected revision and lots, explain the reason and risk, define validation evidence, and obtain the buyer’s written disposition before production parts ship. A practical process distinguishes routine document updates from changes that need samples, requalification, or a new customer approval.
Do not treat an engineering change as only a drawing revision. In production injection molding, an apparently small adjustment to resin source, cavity repair, process window, gauge, or packaging can alter a critical-to-quality result or remove the traceability needed to investigate it.
01
H2: Start With a Written Change-Control Boundary
Put the process in the purchase order, quality agreement, tooling agreement, or a controlled appendix that both parties can identify. Define a change as more than an alteration to the buyer’s CAD. It can include a resin grade, resin producer, colorant, recycled-content level, insert, mold steel or cavity condition, gate or cooling change, production press, molding site, sub-tier operation, inspection method, packaging, or a process parameter outside the approved window.
Before serial supply, freeze the approved revision, resin, tool identification and cavity count, process window, inspection plan, cosmetic standard, packaging, and release evidence in a controlled register. A notice is then a comparison against an approved condition, rather than a debate after shipment. FDA quality-system material frames change control as a way to prevent unintended consequences and calls for considering affected documents, facilities, equipment, materials, and suppliers [3].
02
H2: Classify Changes Before Choosing the Approval Route
Use a simple pre-agreed risk classification. A major change can affect form, fit, function, safety, regulatory status, a critical-to-quality feature, appearance, tool life, or traceability. It needs written buyer approval before implementation and normally pre-agreed validation. A controlled minor change may leave approved characteristics unchanged, but still needs documented notice and disposition. Do not use an administrative correction to conceal an engineering or process change.
Automotive programs may impose their own submission route. For example, Ford’s published customer-specific PPAP requirements list design changes, manufacturing-process changes after PPAP approval, modified tooling or equipment, operating-pattern changes, and capacity changes among PPAP triggers; they also require approval before supplier- or sub-tier-initiated changes are implemented [2]. That is an example, not a universal rule. Buyers should write their customer, market, and contract-specific triggers rather than assume PPAP applies to every program.
| Change class | Typical supplier action | Buyer decision and evidence | Risk if unmanaged |
|---|---|---|---|
| Major product, material, tool, site, or process change | Stop implementation; issue a change notice with reason, affected parts and lots, risk assessment, and validation proposal. | Cross-functional written approval; compare trial or production evidence with the approved baseline before release. | Nonconforming parts, lost approvals, functional failure, or an untraceable field issue. |
| Controlled minor change | Notify against the defined trigger and retain objective records. | Buyer confirms classification, release route, and any additional inspection. | Change accumulation can alter quality without a clear investigation trail. |
| Emergency containment or repair | Protect product, identify affected stock, and record temporary action immediately. | Buyer gives time-bound deviation or release direction; permanent change follows the normal route. | A temporary fix becomes serial practice without validation or expiry. |
03
H2: Make the Notification Complete Enough to Decide
Require a unique change-notice number and a clear effective-date proposal. The supplier should state the part number, drawing and CAD revision, mold number and relevant cavities, current versus proposed condition, business or technical reason, affected work orders and inventory, and whether sub-tier suppliers are involved. Ask for marked-up drawings, photographs of a tool repair where relevant, material data, revised control documents, and a traceability plan. A vague message such as ‘process optimized’ is not a decision record.
The impact assessment should connect the change to CTQs, fit interfaces, appearance zones, material performance, and applicable requirements. It should say what could fail, how it will be detected, action ownership, and how long the decision remains open. This is more useful than a promise of ‘no impact.’ FDA guidance calls for a planned change, justified rationale, implementation plan, and approval before implementation, with ongoing product and process monitoring [1].
04
H2: Match Validation to the Actual Risk
Specify evidence by change type. A new resin producer may need incoming-material confirmation, test data, molded samples, and dimensional and functional comparison. A gate, cooling, cavity, or ejection modification may need a mold trial record, cavity-identified samples, visual review, dimensional results, and a review of cycle stability. A changed gauge or inspection method needs method correlation before data from the new method replace the prior baseline. Do not request every document for every change; request enough evidence to test the stated risk.
Set the acceptance method before the trial: drawing revision, sample selection, CTQs, test methods, cosmetic reference where applicable, lot identification, and release authority. If PPAP, first article inspection, material certification, or a customer-specific dossier is required, state it explicitly. Acceptable-looking samples from an unapproved process are not full production approval.
05
H2: Control Release, Lots, and Communication Across Borders
Use a release gate with named buyer engineering, quality, procurement, and, where necessary, regulatory or operations approvers. The gate should have only clear outcomes: approved, approved with stated conditions, rejected, or pending more evidence. State that no changed production lot may ship as approved before the required written disposition. Where a concession is necessary, record the exact part, lot, quantity, acceptance limit, expiry, and disposition; a concession is not a permanent engineering approval.
For European, US, and Middle East supply chains, make English the controlled master unless the contract says otherwise. Define time-zone convention, units, date and revision formats, escalation contacts, and a secure CAD and tool-data channel. Require the supplier to cascade applicable notice duties to resin, insert, plating, assembly, and packaging sub-tiers. Check local legal and sector requirements before approval.
06
H2: Tie Tool Changes to Injection Mold Ownership and Records
Where the buyer owns or controls the tool, the change process should say who may authorize cutting steel, replacing cavities, changing hot-runner components, permanently repairing a mold, or moving the mold. Identify the tool asset, owner, storage location, approved drawings, backup files, spare-part list, and maintenance record. Separate authorization to inspect or preserve a mold from authorization to modify it. Commercial ownership language and technical approval should point to the same authorized people.
After implementation, update as-built tool, preventive-maintenance, drawing, parameter, control-plan, inspection, and approved-sample records. Retain the notice, evidence, approval, effective lot, and superseded records together. This supports supplier transfer, warranty investigation, and later changes without relying on staff memory.
07
H2: Review the First Changed Production Lots
Release is not the end of control. Agree how the first changed lots will be identified, sampled, inspected, and reviewed. Trend relevant defects, dimensions, yield, cavity variation, and customer feedback against the pre-change baseline. A result outside a control limit or an unexplained drift should reopen the change record, trigger containment, and define whether stock needs segregation or reinspection. The review should distinguish a production problem from an inadequately evaluated change.
Use supplier reviews to test whether notices are complete, on time, correctly classified, and closed with evidence. Repeated late notices, missing sub-tier information, or undocumented ‘temporary’ adjustments signal a need to tighten the gate or audit the process.
08
H2: Send an RFQ With the Change-Control Inputs Included
For an RFQ, provide the latest 2D drawing and CAD, revision, resin and appearance specification, expected volumes, CTQs, test requirements, tool status, packaging, destination market, and any customer-specific approval system. Ask the injection molding supplier for its workflow, contacts, available records, sub-tier controls, emergency-deviation route, and assumptions. Compare the workflow as a supplier-management requirement, not a promise of price, capacity, certification, or delivery date.
A disciplined notification process gives both parties a practical route to improve a tool or process without silently changing the basis on which parts were approved. It protects production injection molding by making the proposed condition, decision rights, evidence, effective lot, and post-change review visible before quality risk reaches the supply chain.
Practical takeaway
Before you move
to the next review.
- Define every change trigger, including material, tool, process, inspection, site, sub-tier, and packaging changes.
- Freeze and retain the approved product, tool, process, inspection, and packaging baseline before serial supply.
- Require a numbered notice showing current versus proposed condition, reason, affected lots, and CTQ risk.
- Name buyer engineering, quality, procurement, and tool-ownership approvers and their release authority.
- Set risk-based validation evidence and acceptance criteria before samples or changed lots are produced.
- Prohibit shipment as approved until the required written disposition is recorded; time-limit any deviation.
- Update as-built tool, control-plan, inspection, and traceability records after implementation and review first lots.
FAQ
Common questions
What should trigger an injection mold engineering change notice?
Trigger notice for any proposed change that can affect the approved product, tool, material, molding process, inspection, site, sub-tier supply, packaging, traceability, or agreed quality evidence. The contract should convert this broad principle into a specific trigger list for the part and market.
Can a molding supplier make an emergency mold repair without prior approval?
The agreement can allow immediate containment to protect safety, product, or the tool, but it should require prompt documentation, lot identification, and buyer direction. A temporary repair or deviation should have an expiry and move through the normal approval and validation route before it becomes the production condition.
Who approves a change to a buyer-owned injection mold?
The tooling agreement should identify the authorized owner representative for technical changes and distinguish that authority from routine storage or maintenance approval. Quality and engineering approval may still be required before parts from the changed mold are released. Ownership alone does not define product acceptance.
Does every supplier change require PPAP?
No. PPAP is commonly used in automotive and may be required by a customer-specific program. Other programs can use first article, dimensional comparison, material confirmation, process records, or another defined evidence package. Match the submission and approval route to the contract, change risk, and sector requirements.
References
Source material
- [1] U.S. Food and Drug Administration, Process Validation: General Principles and Practices
- [2] Ford Motor Company, Customer-Specific Requirements for Production Part Approval Process (PPAP), October 2020
- [3] U.S. Food and Drug Administration, Effective Quality Management Systems: Change Control
This guide is general information for early procurement and engineering discussion. It does not replace product-specific DFM, qualification, validation, regulatory assessment or legal advice.